DCF — HIGHLAND MEDICAL CENTER
Enterprise Value: $-215.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-215.9M
Enterprise Value
$-73.6M
PV of Cash Flows
$-142.3M
PV of Terminal Value
$-229.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $293.6M | $-10.5M | -4.0% | $-23.0M | $-20.9M |
| Year 2 | $302.4M | $-7.8M | -3.0% | $-20.6M | $-17.1M |
| Year 3 | $311.5M | $-5.0M | -2.0% | $-18.1M | $-13.6M |
| Year 4 | $320.9M | $-3.5M | -1.0% | $-17.1M | $-11.7M |
| Year 5 | $330.5M | $-2.8M | -1.0% | $-16.8M | $-10.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-215.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$285.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.040900062445561304
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5